source
- Trump Medicaid pricing plan may give Novo Nordisk unexpected financial boostSTAT reports that the White House introduced a plan aimed at lowering the cost of drugs for Medicaid beneficiaries. The policy includes provisions that reduce prices of obesity treatments for senio…
- Western pharma firms lobby Trump administration to preserve China partnership opportunitiesWestern pharmaceutical companies are urging the Trump administration to permit continued collaborations with Chinese firms on promising drug candidates, despite a 2025 law that limits U.S. investme…